Nephros Inc. (NEPH)
NASDAQ: NEPH
· Real-Time Price · USD
4.29
0.29 (7.25%)
At close: Aug 15, 2025, 9:59 AM
Nephros Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.42M | 4.88M | 3.87M | 3.52M | 3.25M | 3.52M | 3.25M | 3.74M | 3.54M | 3.7M | 2.56M | 2.41M | 2.88M | 2.19M | 2.77M | 2.64M | 2.27M | 2.74M |
Cost of Revenue | 1.62M | 1.72M | 1.4M | 1.37M | 1.34M | 1.33M | 1.23M | 1.55M | 1.47M | 1.59M | 1.05M | 1.65M | 1.52M | 1.16M | 1.3M | 1.23M | 991K | 1.15M |
Gross Profit | 2.79M | 3.15M | 2.48M | 2.15M | 1.91M | 2.19M | 2.02M | 2.19M | 2.08M | 2.11M | 1.51M | 762K | 1.36M | 1.02M | 1.47M | 1.41M | 1.27M | 1.59M |
Operating Income | 248K | 566K | 317K | 206K | -317K | -200K | -649K | -203K | -435K | -306K | -693K | -1.28M | -1.2M | -1.95M | -1.04M | -1.16M | -1.12M | -1.02M |
Interest Income | 31K | 13K | 28K | 20K | 21K | 25K | 28K | 11K | 13K | 12K | 7K | 4K | 1K | 2K | 2K | 2K | 3K | 3K |
Pretax Income | 246K | 558K | 364K | 183K | -289K | -169K | -654K | -182K | -433K | -306K | -719K | -1.25M | -1.14M | -1.97M | -1.04M | -1.16M | -1.13M | -537K |
Net Income | 237K | 558K | 349K | 183K | -289K | -169K | -654K | -182K | -433K | -307K | -944K | -3.23M | -1.14M | -2.04M | -1.1M | -1.22M | -1.19M | -596K |
Selling & General & Admin | 2.2M | 2.25M | 1.87M | 1.72M | 1.94M | 2.14M | 2.41M | 2.14M | 2.24M | 2.12M | 1.79M | 1.74M | 2.07M | 2.35M | 1.97M | 1.89M | 1.85M | 2M |
Research & Development | 311K | 295K | 252K | 188K | 254K | 212K | 208K | 205K | 221K | 239K | 359K | 252K | 431K | 578K | 491K | 632K | 487K | 556K |
Other Expenses | n/a | 39K | 34K | 34K | 34K | 33K | 51K | 45K | 54K | 54K | 56K | 31K | 64K | 52K | 1K | 8K | -1K | 9K |
Operating Expenses | 2.51M | 2.59M | 2.16M | 1.94M | 2.23M | 2.39M | 2.67M | 2.39M | 2.52M | 2.42M | 2.2M | 2.04M | 2.56M | 2.98M | 2.51M | 2.57M | 2.39M | 2.6M |
Interest Expense | 1K | n/a | n/a | n/a | n/a | 1K | 1K | n/a | n/a | 1K | 3K | 4K | 6K | 7K | 7K | 10K | 11K | 13K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.17M | 4.31M | 3.55M | 3.31M | 3.57M | 3.71M | 3.9M | 3.94M | 3.99M | 4M | 3.25M | 3.69M | 4.09M | 4.14M | 3.8M | 3.8M | 3.38M | 3.75M |
Income Tax Expense | 9K | n/a | 15K | n/a | n/a | n/a | -1K | n/a | n/a | 1K | 225K | n/a | -1K | 77K | 7K | 78K | n/a | n/a |
Shares Outstanding (Basic) | 10.6M | 10.6M | 10.54M | 10.54M | 10.51M | 10.5M | 10.54M | 10.46M | 10.3M | 10.3M | 10.3M | 10.3M | 10.3M | 10.21M | 10.04M | 10.04M | 9.94M | 9.88M |
Shares Outstanding (Diluted) | 10.81M | 10.62M | 10.56M | 10.58M | 10.51M | 10.5M | 10.54M | 10.46M | 10.3M | 10.3M | 10.3M | 10.3M | 10.3M | 10.21M | 10.04M | 10.04M | 9.94M | 9.88M |
EPS (Basic) | 0.02 | 0.05 | 0.03 | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 | -0.03 | -0.09 | -0.31 | -0.11 | -0.2 | -0.11 | -0.12 | -0.12 | -0.06 |
EPS (Diluted) | 0.02 | 0.05 | 0.03 | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 | -0.03 | -0.09 | -0.31 | -0.11 | -0.2 | -0.11 | -0.12 | -0.12 | -0.06 |
EBITDA | 282K | 605K | 400K | 217K | -255K | -134K | -602K | -126K | -381K | -251K | -569K | -1.15M | -710K | -1.46M | -896K | -749K | -1.06M | -397K |
EBIT | 247K | 566K | 364K | 183K | -289K | -168K | -653K | -182K | -433K | -305K | -716K | -1.25M | -741K | -1.55M | -1.03M | -792K | -1.11M | -524K |
Depreciation & Amortization | 35K | 39K | 36K | 34K | 34K | 34K | 51K | 56K | 53K | 141K | 147K | 100K | 162K | 174K | 139K | 129K | 132K | 127K |